SMIC, Sinopharm prepare super short-term Pandas

two pandas px230
By Rebecca Feng
09 Oct 2019

Semiconductor Manufacturing International Corp (SMIC) and traditional Chinese medicine maker Sinopharm Group are both plotting their returns to the Panda bond market.

Please take a trial or subscribe to access this content.

Contact our subscriptions team to discuss your access: subs@globalcapital.com

Or sign up for a trial to gain full access to the entire site for a limited period.

Free Trial

Corporate access

To discuss GlobalCapital access for your entire department or company please contact our subscriptions sales team at: subs@globalcapital.com or find out more online here.